Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by John Buse

1-50 of 307 results

View this query on the Wikidata Query Service
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

scientific article
Follow-up report on the diagnosis of diabetes mellitus

scientific article published on November 2003
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

scientific article
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

scientific article published on March 14, 2010
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

scientific article
Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

scientific article
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus

scientific article published on March 14, 2010
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

scientific article
The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

scientific article
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

scientific article
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

scientific article published on 20 April 2012
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes

scientific article published in November 2004
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

scientific article
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

scientific article
Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).

scientific article published on 16 March 2009
Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes

scientific article published on March 3, 2011
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

scientific article published on August 2006
Strategies for multivessel revascularization in patients with diabetes

scientific article
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

scientific article
How do we define cure of diabetes?

scientific article published on November 2009
A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia

scientific article published in July 2005
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

scientific article published on 04 October 2018
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association

scientific article
Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes

scientific article published on 29 June 2010
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

scientific article published in January 2008
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

scientific article
Effect of valsartan on the incidence of diabetes and cardiovascular events

scientific article
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Card

scientific article published on 17 December 2008
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods

article
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

scientific article published on 14 September 2017
Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes

scientific article published on July 2003
Effect of nateglinide on the incidence of diabetes and cardiovascular events

scientific article published on 14 March 2010
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association

scientific article published on January 2007
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition

scientific article
Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes

scientific article published on 06 December 2010
Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial

scientific article
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

scientific article published on April 21, 2012
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial

scientific article
DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks

scientific article published on 9 March 2010
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study

scientific article published in The Lancet
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Card

scientific article published on January 2009
Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change

scientific article published on February 2005
Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

scientific article published on August 2006
Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled tr

scientific article
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes

scientific article published on 12 June 2017
Liraglutide and Renal Outcomes in Type 2 Diabetes

scientific article published on August 2017
Recommendations for management of diabetes during Ramadan: update 2010.

scientific article
Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with typ

scientific article published on September 1, 2014
Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits

scientific article
Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery

scientific article

Paulina is supported by:

About Paulina

Help